Mergin 0.125mg Injection
Prescription Required
Product introduction
Mergin 0.125mg Injection is a medicine used to control bleeding from the uterus, that may occur after childbirth or an abortion. It works on the smooth muscle of the uterus and increases tone, rate, and amplitude of contractions thus reduces blood loss.
Mergin 0.125mg Injection induces a rapid and sustained effect on muscles of womb which shortens the third stage of labor and reduces blood loss
Mergin 0.125mg Injection induces a rapid and sustained effect on muscles of womb which shortens the third stage of labor and reduces blood loss
Uses of Mergin Injection
- Post-delivery bleeding
Benefits of Mergin Injection
In Post-delivery bleeding
Mergin 0.125mg Injection helps to control excessive bleeding after giving birth. This helps to prevent severe loss of blood that can lead to dropping of blood pressure, shock and even death if not controlled in time. It helps proper contraction of the uterus and therefore prevents hemorrhage and further complications.
Side effects of Mergin Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Mergin
- High blood pressure
- Headache
- Seizure
How to use Mergin Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Mergin 0.125mg Injection. Please consult your doctor.
Pregnancy
UNSAFE
Mergin 0.125mg Injection is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Breast feeding
CAUTION
Mergin 0.125mg Injection should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Driving
CONSULT YOUR DOCTOR
It is not known whether Mergin 0.125mg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney
CONSULT YOUR DOCTOR
There is limited information available on the use of Mergin 0.125mg Injection in patients with kidney disease. Please consult your doctor.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Mergin 0.125mg Injection in patients with liver disease. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Mergin 0.125mg Injection
₹20.5/Injection
Ergagin 0.125mg Injection
Mercury Laboratories Ltd
₹15.13/injection
26% cheaper
Gotrin 0.125mg Injection
Rekvina Laboratories Ltd
₹14.81/injection
28% cheaper
Quick tips
- Mergin 0.125mg Injection is used for the prevention and control of post-delivery bleeding.
- It may also be used for the active management of the third stage of labor, to facilitate the delivery of the placenta.
- It is given intravenously (into a vein) or intramuscularly (into the muscle) by a doctor or healthcare provider in a hospital or clinic.
- Its dose may be repeated as required at intervals of 2 to 4 hours.
- It should be avoided in patients, with high blood pressure, and heart disease.
Fact Box
Chemical Class
Ergolines
Habit Forming
No
Therapeutic Class
GYNAECOLOGICAL
Action Class
Uterotonic and abortificient
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- MedIndia. Methylergometrine. [Accessed 3 Aprl. 2019] (online) Available from:
- Methylergometrine. East Hanover, New Jersey: Novartis Pharmaceuticals Corporation; 2012. [Accessed 03 Apr. 2019] (online) Available from:
Marketer details
Name: Shrinivas Gujarat Laboratories Pvt Ltd
Address: 604, Corporate House, Opp. Torrent House, Nr. Dinesh Hall, Ashram Road, Ahmedabad-380 009.
Country of origin: India
Lab tests offered by us
Related/Popular tests
11 people viewed this recentlyMRP
₹20.5
Inclusive of all taxes
1.0 ml in 1 vial
SOLD OUT
Notify me